申请人:SMITHKLINE BEECHAM CORP
公开号:WO2003051906A2
公开(公告)日:2003-06-26
Disclosed are compounds that are non-peptide, reversible inhibitors of type 2 methionine aminopeptidase, having the formula: wherein the formula variables are as defined herein. Also disclosed is the use of such compounds in treating conditions mediated by angiogenesis, such as cancer, haemangioma, proliferative retinopathy, rheumatoid arthritis, atherosclerotic neovascularization, psoriasis, ocular neovascularization and obesity.